This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

ST. LOUIS – Prostate cancer is the second most common cancer in men.  Siteman Cancer Center’s top Urological Surgeon joined FOX 2 to discuss the effectiveness of a new urine test for prostate cancer.

Dr. Andriole is part of an international team of researchers that is evaluating the effectiveness of a new urine test for prostate cancer. The test, called Exodx Prostate.

The test could reduce the need for biopsies of slow-growing, non-aggressive forms of prostate cancer, which often call for close monitoring rather than near-term surgery.

For more information: siteman.Wustl.Edu